Clinical Trials Browser

Phase 4 × Adenoma × Drug Evaluation × Clear all

NCT02032784 2020-07-16

Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding

Phase 4 Terminated

Adenoma